DMH-25
DMH25 is a novel covalent and potent inhibitor of mTOR and shows in vivo antitumor activity against triple-negative breast cancer cells.In vivo, DHM25 was an efficient inhibitor of growth and metastasis of triple-negative breast cancer cells, paving the way for its clinical application in oncology.
Product Specifications
CAS Number
1685280-21-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
489.94
Molecular Formula
C15H8Br3NO3
Notes
Research use only, not for human use.
Receptor
MTOR
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2582907 1.0 µg DNA
UGCGL2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details K3800004 1.0 µg DNA
Calml4 sgRNA CRISPR Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details MBS1060995-01 0.02 mg (E-Coli)
Recombinant Desulfovibrio salexigens Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)
Sign In for Pricing
View Details